These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37344870)

  • 1. HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma.
    He S; Ding Y; Ji Z; Yuan B; Chen J; Ren W
    Cancer Cell Int; 2023 Jun; 23(1):122. PubMed ID: 37344870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma.
    Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G
    Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
    Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
    BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments.
    Bai R; Yin P; Xing Z; Wu S; Zhang W; Ma X; Gan X; Liang Y; Zang Q; Lei H; Wei Y; Zhang C; Dai B; Zheng Y
    Apoptosis; 2024 Apr; 29(3-4):372-392. PubMed ID: 37945816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma.
    Jiang L; Yang Y; Liu F; Ma M; Gao J; Sun L; Chen Y; Shen Z; Wu D
    Front Cell Dev Biol; 2022; 10():859958. PubMed ID: 35399535
    [No Abstract]   [Full Text] [Related]  

  • 8. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.
    Zhang W; Xie X; Huang Z; Zhong X; Liu Y; Cheong KL; Zhou J; Tang S
    Front Immunol; 2022; 13():919145. PubMed ID: 36211371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
    Chen G; Yan J
    Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
    Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
    Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
    Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
    Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
    Long S; Xu J; Huang H
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and immune-related value of STK17B in skin cutaneous melanoma.
    Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J
    PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma.
    Sun Y; Lei S; Luo X; Jiang C; Li Z
    Front Pharmacol; 2023; 14():1129544. PubMed ID: 37138850
    [No Abstract]   [Full Text] [Related]  

  • 17. High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma.
    Zhao S; Wen S; Liu H; Zhou Z; Liu Y; Zhong J; Xie J
    Front Surg; 2022; 9():917776. PubMed ID: 36034394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma.
    Wang H; Xie X; Zhu J; Qi S; Xie J
    Cancer Cell Int; 2021 Dec; 21(1):694. PubMed ID: 34930258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.